CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial (RCT) ...
CHARLOTTESVILLE, Va., May 7, 2026 /PRNewswire/ -- RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
RIVANNA receives US FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound imaging system
RIVANNA, a developer of AI-enabled clinical decision-support solutions, announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro XV Diagnostic Ultrasound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results